Kaye JA - Search Results

1

Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease.

Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Montine TJ, et al. Among authors: kaye ja. J Alzheimers Dis. 2005 Mar;8(4):359-67. doi: 10.3233/jad-2005-8405. J Alzheimers Dis. 2005. PMID: 16556967 Review.

2

Brain volume preserved in healthy elderly through the eleventh decade.

Mueller EA, Moore MM, Kerr DC, Sexton G, Camicioli RM, Howieson DB, Quinn JF, Kaye JA. Mueller EA, et al. Among authors: kaye ja. Neurology. 1998 Dec;51(6):1555-62. doi: 10.1212/wnl.51.6.1555. Neurology. 1998. PMID: 9855501

3

Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.

Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF. Montine TJ, et al. Among authors: kaye ja. Arch Pathol Lab Med. 2001 Apr;125(4):510-2. doi: 10.5858/2001-125-0510-CFATAF. Arch Pathol Lab Med. 2001. PMID: 11260625 Free article.

4

Predictors of healthy brain aging.

Gonzales Mc Neal M, Zareparsi S, Camicioli R, Dame A, Howieson D, Quinn J, Ball M, Kaye J, Payami H. Gonzales Mc Neal M, et al. J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7):B294-301. doi: 10.1093/gerona/56.7.b294. J Gerontol A Biol Sci Med Sci. 2001. PMID: 11445594

5

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Among authors: kaye ja. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

6

Natural history of cognitive decline in the old old.

Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, Dame A, Sexton G, Kaye JA. Howieson DB, et al. Among authors: kaye ja. Neurology. 2003 May 13;60(9):1489-94. doi: 10.1212/01.wnl.0000063317.44167.5c. Neurology. 2003. PMID: 12743237

7

Changes in premorbid brain volume predict Alzheimer's disease pathology.

Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA. Silbert LC, et al. Among authors: kaye ja. Neurology. 2003 Aug 26;61(4):487-92. doi: 10.1212/01.wnl.0000079053.77227.14. Neurology. 2003. PMID: 12939422

8

Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain.

Quinn J, Suh J, Moore MM, Kaye J, Frei B. Quinn J, et al. J Alzheimers Dis. 2003 Aug;5(4):309-13. doi: 10.3233/jad-2003-5406. J Alzheimers Dis. 2003. PMID: 14624026 Clinical Trial.

9

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW Jr, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. Clark CM, et al. Arch Neurol. 2003 Dec;60(12):1696-702. doi: 10.1001/archneur.60.12.1696. Arch Neurol. 2003. PMID: 14676043

10

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Quinn JF, et al. Among authors: kaye ja. J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110. J Alzheimers Dis. 2004. PMID: 15004331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters